Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Cerebral Blood Flow and Metabolism Année : 2020

Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy

Résumé

In eukaryotes, the polyamine pathway generates spermidine that activates the hypusination of the translation factor eukaryotic initiation factor 5A (eIF5A). Hypusinated-eIF5A modulates translation, elongation, termination and mitochondrial function. Evidence in model organisms like drosophila suggests that targeting polyamines synthesis might be of interest against ischemia. However, the potential of targeting eIF5A hypusination in stroke, the major therapeutic challenge specific to ischemia, is currently unknown. Using in vitro models of ischemic-related stress, we documented that GC7, a specific inhibitor of a key enzyme in the eIF5A activation pathway, affords neuronal protection. We identified the preservation of mitochondrial function and thereby the prevention of toxic ROS generation as major processes of GC7 protection. To represent a thoughtful opportunity of clinical translation, we explored whether GC7 administration reduces the infarct volume and functional deficits in an in vivo transient focal cerebral ischemia (tFCI) model in mice. A single GC7 pre- or post-treatment significantly reduces the infarct volume post-stroke. Moreover, GC7-post-treatment significantly improves mouse performance in the rotarod and Morris water-maze, highlighting beneficial effects on motor and cognitive post-stroke deficits. Our results identify the targeting of the polyamine-eIF5A-hypusine axis as a new therapeutic opportunity and new paradigm of research in stroke and ischemic diseases.
Fichier principal
Vignette du fichier
2020-Bourourou-JCBFM.pdf (1.07 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02899981 , version 1 (05-11-2020)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Miled Bourourou, Elsa Gouix, Nicolas Melis, Jonas Friard, Catherine Heurteaux, et al.. Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy. Journal of Cerebral Blood Flow and Metabolism, 2020, pp.0271678X2092888. ⟨10.1177/0271678X20928882⟩. ⟨hal-02899981⟩
38 Consultations
115 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More